Prophylactic use of myelopoietic growth factors in children after myelosuppressive chemotherapy: does it pay?

作者信息

Bessmertny Olga, Cairo Mitchell S

机构信息

Department of Pharmacy, Children's Hospital of New York Presbyterian, Columbia University, New York 10032, USA.

出版信息

J Pediatr Hematol Oncol. 2003 Jun;25(6):435-40. doi: 10.1097/00043426-200306000-00003.

DOI:10.1097/00043426-200306000-00003

PMID:12794520

Abstract

摘要

相似文献

Prophylactic use of myelopoietic growth factors in children after myelosuppressive chemotherapy: does it pay?

J Pediatr Hematol Oncol. 2003 Jun;25(6):435-40. doi: 10.1097/00043426-200306000-00003.

When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?

J Clin Oncol. 2006 Jul 1;24(19):2975-7. doi: 10.1200/JCO.2006.05.6812. Epub 2006 May 8.

Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapy.

Value Health. 2011 Mar-Apr;14(2):253-62. doi: 10.1016/j.jval.2010.09.010.

The role of myelopoietic growth factors in managing cancer in the elderly.

Drugs. 2002;62 Suppl 1:47-63. doi: 10.2165/00003495-200262001-00004.

[Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].

Farm Hosp. 2010 Mar;34 Suppl 1:8-11. doi: 10.1016/S1130-6343(10)70002-7.

Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.

J Pediatr Hematol Oncol. 2003 Jun;25(6):441-7. doi: 10.1097/00043426-200306000-00004.

Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia.

Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):699-709. doi: 10.1586/erp.12.64.

Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer.

Stem Cells. 1995 May;13(3):289-94. doi: 10.1002/stem.5530130310.

Colony-stimulating factors for the management of neutropenia in cancer patients.

Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001.

Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.

Pharmacoeconomics. 2003;21(18):1295-313. doi: 10.1007/BF03262329.

引用本文的文献

Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.

Pharmacoeconomics. 2003;21(18):1295-313. doi: 10.1007/BF03262329.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验